INS and Insulin resistance: Our results showed that eight weeks of oral administration of HFD has increased serum FFAs by 29.8% (p < 0.01), and serum insulin level by 68.8% (p < 0.01) and HOMA-IR by 75.7% (p < 0.01), indicating that rats the HFD developed distinct insulin resistance.